Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 28

Sort by

Sort Order Select

Journal Articles

Memory B-cell reconstitution following allogeneic hematopoietic stem cell transplantation is an EBV-associated transformation event

David M. Burns, Rose Tierney, Claire Shannon-Lowe, Jo Croudace, Charlotte Inman, Ben Abbotts, Sandeep Nagra, Christopher P. Fox, Sridhar Chaganti, Charles F. Craddock, Paul Moss, Alan B. Rickinson, Martin Rowe, Andrew I. Bell

Blood (2015) 126 (25): 2665–2675.

https://doi.org/10.1182/blood-2015-08-665000

Published: 2015

Includes: Supplemental data

Journal Articles

Impact of HLA of Winning Cord Blood Unit on Outcomes after Double Umbilical Cord Blood Transplantation in Adults with Acute Leukemia: A Retrospective Study on Behalf of Eurocord, the Cord Blood Committee Cellular Therapy and Immunobiology Working Party and the Acute Leukemia Working Party of the EBMT

Blood (2015) 126 (23): 3111.

https://doi.org/10.1182/blood.V126.23.3111.3111

Published: 2015

Journal Articles

Transfusion of CMV Seronegative T-Deplete Allogeneic Stem Cell Transplant Recipients with CMV Unselected Blood Products Confers a Zero Risk of CMV Transmission in the Era of Universal Leucodepletion: A UK Single-Centre Experience

Suzanne Hall, MB BCh, FRCPath, Sandeep Nagra, MBChB, Husam Osman, MB BCh, Mark Cook, PhD FRCPath, Charles F. Craddock, BM, MRCP, MRCPath, Sridhar Chaganti, MD PhD

Blood (2014) 124 (21): 2894.

https://doi.org/10.1182/blood.V124.21.2894.2894

Published: 2014

Journal Articles

Early Multilineage Chimerism Predicts The ‘Winning’ Unit In Double Cord Blood Transplantation

Rachael E Hough, MD, Bronwen E. Shaw, MBChB, MRCP, PhD, FRCPath, Pip Patrick, Nigel Russell, MD, Antonio Pagliuca, MBBS, FRCP, FRCPath, MA, Charles F. Craddock, BM, MRCP, MRCPath, Eleni Tholouli, Gordon Cook, MD, PhD, David I Marks

Blood (2013) 122 (21): 300.

https://doi.org/10.1182/blood.V122.21.300.300

Published: 2013

Journal Articles

BEAM-Campath Allogeneic Stem Cell Transplantation for Aggressive Non-Hodgkin's Lymphomas. An Analysis of Outcomes From the BSBMT

Stephen Robinson, MBBS, MRCP, FRCPath, PhD, Christopher P Fox, MBChB, MRCP, FRCPath, Rachel M Pearce, Julia Perry, Keiren Kirkland, Charles F. Craddock, BM, MRCP, MRCPath, Nigel H Russell, MD, Grant McQuaker, MD, Antonio Pagliuca, Peter R. E. Johnson, MD, Gordon Cook, MD PhD

Blood (2012) 120 (21): 2039.

https://doi.org/10.1182/blood.V120.21.2039.2039

Published: 2012

Journal Articles

Cidofovir Is a Highly Effective and Safe Salvage Therapy in Ganciclovir Resistant Cytomegalovirus Reactivation Following Allogeneic Haematopoietic Stem Cell Transplantation

David Lewis, Francesca Farina, Sandeep Nagra, Sridhar Chaganti, Annette Pachnio, PhD, Jane Nunnick, Paul AH Moss, MD PhD, Ram Malladi, Charles F. Craddock, BM, MRCP, MRCPath

Blood (2012) 120 (21): 1923.

https://doi.org/10.1182/blood.V120.21.1923.1923

Published: 2012

Journal Articles

Residual Disease Detection by Flow Cytometry Predicts Risk of Relapse and Overall Survival in Patients with Acute Myeloid Leukemia Following Reduced Intensity- and Myeloablative- Allogeneic Hematopoietic Cell Transplantation

Charlotte Ann Bradbury, MA BM BCh MRCP FRCPATH, Janice Ward, Paresh Vyas, DPhil, FRCP, FRCPath, Nigel H. Russell, MD, Grimwade David, Robert K Hills, Alan K. Burnett, Charles F. Craddock, BM, MRCP, MRCPath, Freeman Sylvie

Blood (2012) 120 (21): 4098.

https://doi.org/10.1182/blood.V120.21.4098.4098

Published: 2012

Journal Articles

Equivalent Outcome Between Older Siblings and Unrelated Donors After Reduced Intensity Allogeneic Hematopoietic Stem Cell Transplantation for Patients Older Than 50 Years with Acute Myeloid Leukemia in First Complete Remission: A Report From the ALWP of EBMT

Regis Peffault de Latour, Myriam Labopin, Jan Cornelissen, MD PhD, Lars Vindelov, MD, Didier Blaise, MD, Noel Milpied, MD, Anne Huyn, MD, Charles F. Craddock, BM, MRCP, MRCPath, Nigel Russel, Vladimir Koza, MD, Bruno Lioure, MD, Richard Schouten, BSc, Dolores Caballero, MD, Jean-Yves Cahn, MD, Nathalie Fegueux, MD, Mohamad Mohty, MD PhD

Blood (2012) 120 (21): 961.

https://doi.org/10.1182/blood.V120.21.961.961

Published: 2012

Journal Articles

Azacitidine augments expansion of regulatory T cells after allogeneic stem cell transplantation in patients with acute myeloid leukemia (AML)

Blood (2012) 119 (14): 3361–3369.

https://doi.org/10.1182/blood-2011-09-377044

Published: 2012

Includes: Supplemental data

Journal Articles

Quantitation of Leukemic Stem Cell Populations Predicts Clinical Outcome in Acute Myeloid Leukaemia

Charles F. Craddock, MD PhD, Nicolas Goardon, PhD, Lynn Quek, MD, Sylvie Freeman, MD, PhD, Shamyla Siddique, Manoj Raghavan, Anna Schuh, PhD, David Grimwade, PhD, Robert K Hills, MA, MSc, DPhil, Cassandra Brookes, PhD, Michael Griffiths, PhD, James D. Cavenagh, MD, Ravindra Majeti, MD, PhD, Irving L. Weissman, MD, Alan K Burnett, MD, Paresh Vyas

Blood (2011) 118 (21): 638.

https://doi.org/10.1182/blood.V118.21.638.638

Published: 2011

Journal Articles

Cryopreservation of Peripheral Blood Stem Cells From Matched Related and Unrelated Donors Is Associated with Delayed Neutrophil and Platelet Engraftment but Does Not Influence Relapse-Free Survival

Patrick G Medd, PhD, FRCPath, Sandeep Nagra, Daniel Hollyman, Charles F. Craddock, BM, MRCP, MRCPath, Ram Malladi

Blood (2011) 118 (21): 2998.

https://doi.org/10.1182/blood.V118.21.2998.2998

Published: 2011

Journal Articles

Azacitidine Induces Expansion of Regulatory T Cells and Tumour Specific CD8+ T Lymphocytes After Allogeneic Stem Cell Transplantation: A Strategy for Epigenetic Manipulation of a Graft-Versus-Leukemia Response

Mike Dennis, Oliver Goodyear, Justin Loke, Nadiria Jilani, Shamyla Siddique, Gordon Ryan, Rehela Khanum, John Snowden, Michael Griffiths, PhD, Nigel H. Russell, MD, John Yin, MD, Charles Crawley, MD, Gordon Cook, MD, PhD, Paresh Vyas, DPhil, FRCP, FRCPath, Paul AH Moss, MD PhD, Ram Malladi, Charles F. Craddock, BM, MRCP, MRCPath

Blood (2011) 118 (21): 324.

https://doi.org/10.1182/blood.V118.21.324.324

Published: 2011

Journal Articles

A Comparison of Stem Cell Source in Adult and Paediatric Recipients of T-Cell Depleted Myeloablative Transplants for Standard Risk Leukaemia: No Difference in Mortality Using BM or PBSC.

Bronwen E Shaw, Jane Apperley, Nigel H. Russell, MD, Charles F. Craddock, BM, MRCP, MRCPath, Effie Liakopoulou, Michael N Potter, Robert Wynn, MRCP, FRCPath, MD, Brenda ES Gibson, R. Pearce, Keiren Kirkland, Alejandro Madrigal, Gordon Cook, MD, PhD, Jennifer L Byrne, PhD

Blood (2009) 114 (22): 1205.

https://doi.org/10.1182/blood.V114.22.1205.1205

Published: 2009

Journal Articles

The Epigenetic Therapies Azacitidine and Sodium Valproate Augment Immune Responses to the MAGE Cancer Testis Antigen in Acute Myeloid Leukemia and Myeloma.

Oliver Charles Goodyear, PhD, Angelo Agathanggelou, PhD, Gordon Ryan, Igor Novitsky-Basso, Tatjana Stankovic, MD., PhD, Paul Moss, MBBS, PhD, FRCP, Charles F. Craddock, BM, MRCP, MRCPath

Blood (2009) 114 (22): 2086.

https://doi.org/10.1182/blood.V114.22.2086.2086

Published: 2009

Journal Articles

Cyclosporine dose Intensity Is a Critical Determinant of Outcome after a T Cell Depleted Reduced Intensity Allograft.

Charles F. Craddock, BM, MRCP, MRCPath, Sandeep Nagra, Cassandra Brookes, Nick Duncan, Alison H Thomson, Prem Mahendra, Janice Ward, Fiona Clark, Paul Moss, Mark Cook

Blood (2008) 112 (11): 1153.

https://doi.org/10.1182/blood.V112.11.1153.1153

Published: 2008

Journal Articles

Reduced CD38 Expression on CD34+ Cells as a Diagnostic Test in Myelodysplastic Syndromes

Paresh Vyas, DPhil, FRCP, FRCPath, Nicolas Goardon, PhD, Alexander Sternberg, MRCP, FRCPath, Wai-Kit Chu, Charles F. Craddock, BM, MRCP, MRCPath, Richard Benson, FRCS, Sylvie Freeman, BM, MRCP, FRCPath

Blood (2008) 112 (11): 2670.

https://doi.org/10.1182/blood.V112.11.2670.2670

Published: 2008

Journal Articles

Pretransplant Characteristics Could Predict Full Donor Chimerism on Day +90 and Day +180 and Outcomes in Reduced Intensity Alemtuzumab Conditioning Allogeneic Transplantation Can Be Influenced by Chimeric Status

Emmanouil Nikolousis, Charles F. Craddock, BM, MRCP, MRCPath, Shankaranarayana Paneesha, MD, Sudhir Tauro, Prem Mahendra, II, Mark Cook, Fiona Clark, Richard Lovell, Sridhar Chaganti, Donald Milligan, MD, MBChB, Dominique Mcmullan, Mike Griffiths, Stephen P Robinson, MD

Blood (2008) 112 (11): 4409.

https://doi.org/10.1182/blood.V112.11.4409.4409

Published: 2008

Journal Articles

T-Cell Depleted Unrelated Donor Stem Cell Transplants Appear to Be of Value for Adult Philadelphia Chromosome Negative ALL Patients and Should Be Evaluated Prospectively in New Large Group Studies

B. R Patel, Keiren Kirkland, R. Pearce, Richard E Clark, Charles F. Craddock, BM, MRCP, MRCPath, Effie Liakopolou, Adele K Fielding, PhD, Stephen Mackinnon, MD, Eduardo Olavarria, MD, Michael N Potter, Nigel H. Russell, MD, Bronwen E. Shaw, Anthony H. Goldstone, FRCP, FRCPath, David I Marks, MD

Blood (2008) 112 (11): 4413.

https://doi.org/10.1182/blood.V112.11.4413.4413

Published: 2008

Journal Articles

Identification of Prognostic Factors Predicting the Outcome of Reduced Intensity Allogeneic Stem Cell Transplantation in Mantle Cell Lymphoma. An Analysis from the Lymphoma Working Party of the EBMT

Stephen P Robinson, Anna Sureda, Carmen Canals, Sr., Jean-Paul Vernant, Noel-Jean Milpied, PhD, Jürgen Finke, Johan Maertens, Jean-Pierre Jouet, MD, Charles F. Craddock, BM, MRCP, MRCPath, Karl S Peggs, MD, Steven Le Gouill, MD, Norbert Schmitz, MD, PhD

Blood (2008) 112 (11): 457.

https://doi.org/10.1182/blood.V112.11.457.457

Published: 2008

Journal Articles

Factors Determining Survival after Unrelated Donor Stem Cell Transplantation in Primary Refractory Acute Myeloid Leukemia

Charles F. Craddock, BM, MRCP, MRCPath, Myriam Labopin, J. ürgen Finke, Gerhard Ehninger, MD, Donald Bunjes, Hans-Jochem Kolb, Hildegard Greinix, Axel Zander, Emmanuelle Polge, Christoph Schmid, Dietrich Beelen, Vanderson Rocha

Blood (2008) 112 (11): 564.

https://doi.org/10.1182/blood.V112.11.564.564

Published: 2008

NARROW

Memory B-cell reconstitution following allogeneic hematopoietic stem cell transplantation is an EBV-associated transformation event

Transfusion of CMV Seronegative T-Deplete Allogeneic Stem Cell Transplant Recipients with CMV Unselected Blood Products Confers a Zero Risk of CMV Transmission in the Era of Universal Leucodepletion: A UK Single-Centre Experience

Early Multilineage Chimerism Predicts The ‘Winning’ Unit In Double Cord Blood Transplantation

BEAM-Campath Allogeneic Stem Cell Transplantation for Aggressive Non-Hodgkin's Lymphomas. An Analysis of Outcomes From the BSBMT

Cidofovir Is a Highly Effective and Safe Salvage Therapy in Ganciclovir Resistant Cytomegalovirus Reactivation Following Allogeneic Haematopoietic Stem Cell Transplantation

Residual Disease Detection by Flow Cytometry Predicts Risk of Relapse and Overall Survival in Patients with Acute Myeloid Leukemia Following Reduced Intensity- and Myeloablative- Allogeneic Hematopoietic Cell Transplantation

Equivalent Outcome Between Older Siblings and Unrelated Donors After Reduced Intensity Allogeneic Hematopoietic Stem Cell Transplantation for Patients Older Than 50 Years with Acute Myeloid Leukemia in First Complete Remission: A Report From the ALWP of EBMT

Azacitidine augments expansion of regulatory T cells after allogeneic stem cell transplantation in patients with acute myeloid leukemia (AML)

Quantitation of Leukemic Stem Cell Populations Predicts Clinical Outcome in Acute Myeloid Leukaemia

Cryopreservation of Peripheral Blood Stem Cells From Matched Related and Unrelated Donors Is Associated with Delayed Neutrophil and Platelet Engraftment but Does Not Influence Relapse-Free Survival

Azacitidine Induces Expansion of Regulatory T Cells and Tumour Specific CD8+ T Lymphocytes After Allogeneic Stem Cell Transplantation: A Strategy for Epigenetic Manipulation of a Graft-Versus-Leukemia Response

A Comparison of Stem Cell Source in Adult and Paediatric Recipients of T-Cell Depleted Myeloablative Transplants for Standard Risk Leukaemia: No Difference in Mortality Using BM or PBSC.

The Epigenetic Therapies Azacitidine and Sodium Valproate Augment Immune Responses to the MAGE Cancer Testis Antigen in Acute Myeloid Leukemia and Myeloma.

Cyclosporine dose Intensity Is a Critical Determinant of Outcome after a T Cell Depleted Reduced Intensity Allograft.

Reduced CD38 Expression on CD34+ Cells as a Diagnostic Test in Myelodysplastic Syndromes

Pretransplant Characteristics Could Predict Full Donor Chimerism on Day +90 and Day +180 and Outcomes in Reduced Intensity Alemtuzumab Conditioning Allogeneic Transplantation Can Be Influenced by Chimeric Status

T-Cell Depleted Unrelated Donor Stem Cell Transplants Appear to Be of Value for Adult Philadelphia Chromosome Negative ALL Patients and Should Be Evaluated Prospectively in New Large Group Studies

Identification of Prognostic Factors Predicting the Outcome of Reduced Intensity Allogeneic Stem Cell Transplantation in Mantle Cell Lymphoma. An Analysis from the Lymphoma Working Party of the EBMT

Factors Determining Survival after Unrelated Donor Stem Cell Transplantation in Primary Refractory Acute Myeloid Leukemia

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only